Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


20.02.2017

1 Am J Respir Crit Care Med
2 Ann Oncol
1 Ann Surg Oncol
1 Ann Thorac Surg
2 Anticancer Res
2 BMC Cancer
1 Br J Cancer
1 Cancer Cell
2 Cancer Lett
4 Cancer Res
8 Cancer Sci
2 Carcinogenesis
1 Chest
2 Clin Cancer Res
9 Clin Lung Cancer
1 Clin Nucl Med
4 Eur J Cardiothorac Surg
1 Int J Cancer
1 Int J Oncol
11 J Cancer Res Clin Oncol
1 J Clin Oncol
5 J Surg Oncol
4 J Thorac Oncol
1 Mol Cancer Ther
1 Nat Med
1 Oncogene
2 Oncol Rep
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. CORREIA LL, Johnson JA, McErlean P, Bauer J, et al
    SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer.
    Am J Respir Crit Care Med. 2017 Feb 15. doi: 10.1164/rccm.201510-2084.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. TANG H, Wang S, Xiao G, Schiller J, et al
    Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies.
    Ann Oncol. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    

  3. ZHANG L, Ye Y, Tu H, Hildebrandt MA, et al
    MicroRNA Related Genetic Variants in Iron Regulatory Genes, Dietary Iron Intake, MicroRNAs and Lung Cancer Risk.
    Ann Oncol. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


    Ann Surg Oncol

  4. PEZZI TA, Mohamed AS, Fuller CD, Blanchard P, et al
    Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2017 Feb 2. doi: 10.1245/s10434-017-5786.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. NISHIO W
    Careful indications for intentional segmentectomy in cT1aN0 non-small cell lung cancer (Reply).
    Ann Thorac Surg. 2017 Feb 2. pii: S0003-4975(17)30085.
    PubMed     Text format    


    Anticancer Res

  6. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Radiation Pneumonitis Changes over Time after Stereotactic Body Radiation Therapy for Lung Tumors: Post-treatment Cavity (Sunny-side-up Egg-like) Changes.
    Anticancer Res. 2016;36:5563-5570.
    PubMed     Text format     Abstract available

  7. VAN DER MEER FS, Schramel FM, VAN Vulpen M, El Sharouni SY, et al
    Feasibility of Concomitant Chemoradiotherapy in Daily Practice for Patients with NSCLC Stage III.
    Anticancer Res. 2016;36:4673-6.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. SHI L, Xu Z, Wu G, Chen X, et al
    Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.
    BMC Cancer. 2017;17:138.
    PubMed     Text format     Abstract available

  9. ZHANG L, Liu D, Li L, Pu D, et al
    The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    BMC Cancer. 2017;17:96.
    PubMed     Text format     Abstract available


    Br J Cancer

  10. PRUITT SL, Laccetti AL, Xuan L, Halm EA, et al
    Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.
    Br J Cancer. 2017 Feb 14. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer Cell

  11. GARDNER EE, Lok BH, Schneeberger VE, Desmeules P, et al
    Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
    Cancer Cell. 2017;31:286-299.
    PubMed     Text format     Abstract available


    Cancer Lett

  12. HONG SK, Park JR, Kwon OS, Kim KT, et al
    Induction of integrin beta3 by sustained ERK activity promotes the invasiveness of TGFbeta-induced mesenchymal tumor cells.
    Cancer Lett. 2016;376:339-46.
    PubMed     Text format     Abstract available

  13. WANG Y, Fu L, Cui M, Wang Y, et al
    Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1.
    Cancer Lett. 2017 Feb 12. pii: S0304-3835(17)30078.
    PubMed     Text format     Abstract available


    Cancer Res

  14. NUKAGA S, Yasuda H, Tsuchihara K, Hamamoto J, et al
    Amplification of EGFR wild type alleles in non-small cell lung cancer cells confers acquired resistance to mutation-selective EGFR tyrosine kinase inhibitors.
    Cancer Res. 2017 Feb 15. pii: canres.2359.2016.
    PubMed     Text format     Abstract available

  15. KAREKLA E, Liao WJ, Sharp B, Pugh J, et al
    Ex vivo explant cultures of non-small cell lung carcinoma enable evaluation of primary tumor responses to anticancer therapy.
    Cancer Res. 2017 Feb 15. pii: canres.1121.2016.
    PubMed     Text format     Abstract available

  16. ZHANG Y, Wei Y, Jiang B, Chen L, et al
    Scavenger receptor A1 prevents metastasis of non-small cell lung cancer via suppression of macrophage serum amyloid A1.
    Cancer Res. 2017 Feb 15. pii: canres.1569.2016.
    PubMed     Text format     Abstract available

  17. WANG M, Han J, Marcar L, Black J, et al
    Radiation resistance in KRAS-mutated lung cancer is enabled by stem-like properties mediated by an osteopontin-EGFR pathway.
    Cancer Res. 2017 Feb 15. pii: canres.0808.2016.
    PubMed     Text format     Abstract available


    Cancer Sci

  18. KAKUMU T, Sato M, Goto D, Kato T, et al
    Identification of Proteasomal Catalytic Subunit PSMA6 as a Therapeutic Target for Lung Cancer.
    Cancer Sci. 2017 Feb 6. doi: 10.1111/cas.13185.
    PubMed     Text format     Abstract available

  19. ITO T, Matsubara D, Tanaka I, Makiya K, et al
    Loss of YAP1 defines neuroendocrine differentiation of lung tumors.
    Cancer Sci. 2016;107:1527-1538.
    PubMed     Text format     Abstract available

  20. HIBI M, Kaneda H, Tanizaki J, Sakai K, et al
    FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
    Cancer Sci. 2016;107:1667-1676.
    PubMed     Text format     Abstract available

  21. HIDA T, Nakagawa K, Seto T, Satouchi M, et al
    Pharmacologic study (JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapy.
    Cancer Sci. 2016;107:1642-1646.
    PubMed     Text format     Abstract available

  22. CHEN Y, Yang J, Li X, Hao D, et al
    First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated lung adenocarcinoma.
    Cancer Sci. 2016;107:1800-1805.
    PubMed     Text format     Abstract available

  23. SUZUI M, Futakuchi M, Fukamachi K, Numano T, et al
    Multiwalled carbon nanotubes intratracheally instilled into the rat lung induce development of pleural malignant mesothelioma and lung tumors.
    Cancer Sci. 2016;107:924-35.
    PubMed     Text format     Abstract available

  24. ABE S, Kaneko MK, Tsuchihashi Y, Izumi T, et al
    Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model.
    Cancer Sci. 2016;107:1198-205.
    PubMed     Text format     Abstract available

  25. SUNADA S, Kanai H, Lee Y, Yasuda T, et al
    Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair.
    Cancer Sci. 2016;107:1250-5.
    PubMed     Text format     Abstract available


    Carcinogenesis

  26. WU H, Liu Y, Shu XO, Cai Q, et al
    MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.
    Carcinogenesis. 2016;37:567-75.
    PubMed     Text format     Abstract available

  27. LI R, Gu J, Heymach JV, Shu X, et al
    Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
    Carcinogenesis. 2017 Feb 10. doi: 10.1093.
    PubMed     Text format    


    Chest

  28. DETTERBECK FC
    Achieving Clarity About Lung Cancer and Opacities.
    Chest. 2017;151:252-254.
    PubMed     Text format    


    Clin Cancer Res

  29. LAKSHMANAN I, Salfity S, Seshacharyulu P, Rachagani S, et al
    MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53.
    Clin Cancer Res. 2017 Feb 14. pii: clincanres.2530.2016.
    PubMed     Text format     Abstract available

  30. VAN DER WEKKEN A, Pelgrim R, 't Hart N, Werner N, et al
    Dichotomous ALK-IHC is a better predictor for ALK inhibition outcome than traditional ALK-FISH in advanced non-small cell lung cancer.
    Clin Cancer Res. 2017 Feb 9. pii: clincanres.1631.2016.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  31. NIEDER C, Tollali T, Haukland E, Reigstad A, et al
    External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2017 Jan 19. pii: S1525-7304(17)30021.
    PubMed     Text format     Abstract available

  32. JANSSENS A, Derijcke S, Lefebure A, Vandenbroucke E, et al
    Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study.
    Clin Lung Cancer. 2017 Jan 20. pii: S1525-7304(17)30001.
    PubMed     Text format     Abstract available

  33. RAPHAEL J, Chan K, Karim S, Kerbel R, et al
    Antiangiogenic Therapy in Advanced Non-small-cell Lung Cancer: A Meta-analysis of Phase III Randomized Trials.
    Clin Lung Cancer. 2017 Jan 12. pii: S1525-7304(17)30004.
    PubMed     Text format     Abstract available

  34. SOCINSKI MA, Chaft JE, Levy B, Riely GJ, et al
    The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis.
    Clin Lung Cancer. 2017 Jan 5. pii: S1525-7304(16)30377.
    PubMed     Text format    

  35. PARK CK, Oh IJ, Kim KS, Choi YD, et al
    Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non-Small-cell Lung Cancer: A TRAIL Trial.
    Clin Lung Cancer. 2017 Jan 11. pii: S1525-7304(17)30002.
    PubMed     Text format     Abstract available

  36. DINGLIN XX, Ma SX, Wang F, Li DL, et al
    Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
    Clin Lung Cancer. 2017 Jan 13. pii: S1525-7304(16)30392.
    PubMed     Text format     Abstract available

  37. SUNG MR, Patel MV, Djalalov S, Le LW, et al
    Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade.
    Clin Lung Cancer. 2017 Jan 5. pii: S1525-7304(16)30386.
    PubMed     Text format     Abstract available

  38. REMICK JS, Schonewolf C, Gabriel P, Doucette A, et al
    First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jan 5. pii: S1525-7304(16)30385.
    PubMed     Text format     Abstract available

  39. BRADBURY P, Sivajohanathan D, Chan A, Kulkarni S, et al
    Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2016 Jul 12. pii: S1525-7304(16)30181.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  40. BAI X, Zhuang H
    Prominent Pulmonary Metastases Without Concurrent Osseous Involvement in Patients With High-Risk Neuroblastoma.
    Clin Nucl Med. 2017 Feb 13. doi: 10.1097/RLU.0000000000001579.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  41. BILLE A, Woo KM, Ahmad U, Rizk NP, et al
    Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Eur J Cardiothorac Surg. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    

  42. MOKHLES S, Macbeth F, Treasure T, Younes RN, et al
    Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis.
    Eur J Cardiothorac Surg. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format    

  43. SZANTO Z, Benko I, Jakab L, Szalai G, et al
    The use of a smartphone application for fast lung cancer risk assessmentdagger.
    Eur J Cardiothorac Surg. 2017 Feb 10. doi: 10.1093.
    PubMed     Text format    

  44. DENG HY, Wang YC, Ni PZ, Li G, et al
    Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017;51:203-210.
    PubMed     Text format    


    Int J Cancer

  45. LIN TY, Hsu HY, Sun WH, Wu TH, et al
    Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer.
    Int J Cancer. 2017 Feb 15. doi: 10.1002/ijc.30649.
    PubMed     Text format     Abstract available


    Int J Oncol

  46. XIONG Y, Wang M, Zhao J, Wang L, et al
    SIRT3 is correlated with the malignancy of non-small cell lung cancer.
    Int J Oncol. 2017 Feb 2. doi: 10.3892/ijo.2017.3868.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  47. DE FREITAS AC, Gurgel AP, de Lima EG, de Franca Sao Marcos B, et al
    Human papillomavirus and lung cancinogenesis: an overview.
    J Cancer Res Clin Oncol. 2016;142:2415-2427.
    PubMed     Text format     Abstract available

  48. YAO S, Zhong L, Liu J, Feng J, et al
    Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2016;142:2541-2549.
    PubMed     Text format     Abstract available

  49. SHIMIZU K, Kirita K, Aokage K, Kojima M, et al
    Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2017;143:321-328.
    PubMed     Text format     Abstract available

  50. LUO J, Huang Q, Wang R, Han B, et al
    Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    J Cancer Res Clin Oncol. 2016;142:2031-40.
    PubMed     Text format     Abstract available

  51. XIAO CZ, Wei W, Guo ZX, Zhang MY, et al
    MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    J Cancer Res Clin Oncol. 2017;143:263-273.
    PubMed     Text format     Abstract available

  52. GOTO M, Naito M, Saruwatari K, Hisakane K, et al
    The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017;143:215-223.
    PubMed     Text format     Abstract available

  53. XU Y, Zhu C, Qian W, Zheng M, et al
    Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
    J Cancer Res Clin Oncol. 2017;143:181-186.
    PubMed     Text format     Abstract available

  54. LUO J, Wang R, Han B, Zhang J, et al
    Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
    J Cancer Res Clin Oncol. 2016;142:1837-45.
    PubMed     Text format     Abstract available

  55. NI JY, Xu LF, Wang WD, Huang QS, et al
    Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1alpha for hepatocellular carcinoma: a preliminary study of rat model.
    J Cancer Res Clin Oncol. 2017;143:199-207.
    PubMed     Text format     Abstract available

  56. HUBER JM, Amann A, Koeck S, Lorenz E, et al
    Evaluation of assays for drug efficacy in a three-dimensional model of the lung.
    J Cancer Res Clin Oncol. 2016;142:1955-66.
    PubMed     Text format     Abstract available

  57. DUARTE CW, Black AW, Lucas FL, Vary CP, et al
    Cancer incidence in patients with hereditary hemorrhagic telangiectasia.
    J Cancer Res Clin Oncol. 2017;143:209-214.
    PubMed     Text format     Abstract available


    J Clin Oncol

  58. NEAL JW, Wakelee HA
    Elusive Target of Angiogenesis in Small-Cell Lung Cancer.
    J Clin Oncol. 2017 Feb 6:JCO2016716084. doi: 10.1200/JCO.2016.71.6084.
    PubMed     Text format    


    J Surg Oncol

  59. BI Y, Deng Y, Li S, Zhou X, et al
    Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts.
    J Surg Oncol. 2016;114:697-702.
    PubMed     Text format     Abstract available

  60. JAKUBOWSKI CD, Vertosick EA, Untch BR, Sjoberg D, et al
    Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites.
    J Surg Oncol. 2016;114:375-9.
    PubMed     Text format     Abstract available

  61. PASSOT G, Vaudoyer D, Villeneuve L, Kepenekian V, et al
    What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.
    J Surg Oncol. 2016;113:796-803.
    PubMed     Text format     Abstract available

  62. RICHARDSON K, Potter M, Damron TA
    Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions.
    J Surg Oncol. 2016;113:818-22.
    PubMed     Text format     Abstract available

  63. LEE S, Lee JG, Lee CY, Kim DJ, et al
    Pulmonary fissure development is a prognostic factor for patients with resected stage I lung adenocarcinoma.
    J Surg Oncol. 2016;114:848-852.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  64. GUIBERT N, Barlesi F, Descourt R, Lena H, et al
    Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France.
    J Thorac Oncol. 2017 Feb 9. pii: S1556-0864(17)30097.
    PubMed     Text format     Abstract available

  65. SUDA K, Murakami I, Yu H, Kim J, et al
    Heterogeneity in immune marker expression after acquisition of resistance to EGFR kinase inhibitors: analysis of a case with small cell lung cancer transformation.
    J Thorac Oncol. 2017 Feb 10. pii: S1556-0864(17)30098.
    PubMed     Text format     Abstract available

  66. BAGGSTROM MQ, Socinski MA, Wang XF, Gu L, et al
    Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced Stage IIIB/IV Non-small cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study - CALGB 30607 (Alliance).
    J Thorac Oncol. 2017 Feb 1. pii: S1556-0864(17)30089.
    PubMed     Text format     Abstract available

  67. SONI PD, Boonstra PS, Schipper MJ, Bazzi L, et al
    Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer.
    J Thorac Oncol. 2016 Nov 26. pii: S1556-0864(16)33535.
    PubMed     Text format     Abstract available


    Mol Cancer Ther

  68. HUSAIN H, Scur M, Murtuza A, Bui N, et al
    Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer.
    Mol Cancer Ther. 2017;16:265-272.
    PubMed     Text format     Abstract available


    Nat Med

  69. CHUANG CH, Greenside PG, Rogers ZN, Brady JJ, et al
    Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis.
    Nat Med. 2017 Feb 13. doi: 10.1038/nm.4285.
    PubMed     Text format     Abstract available


    Oncogene

  70. SHI ZM, Wang L, Shen H, Jiang CF, et al
    Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    Oncol Rep

  71. SU J, Yan Y, Qu J, Xue X, et al
    Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-kappaB pathway.
    Oncol Rep. 2017;37:1565-1572.
    PubMed     Text format     Abstract available

  72. LI K, Yang M, Liang N, Li S, et al
    Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review).
    Oncol Rep. 2017;37:1347-1358.
    PubMed     Text format     Abstract available


    PLoS One

  73. KAWAZOE H, Yano A, Ishida Y, Takechi K, et al
    Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.
    PLoS One. 2017;12:e0171066.
    PubMed     Text format     Abstract available

  74. SOK SP, Arshad NM, Azmi MN, Awang K, et al
    The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.
    PLoS One. 2017;12:e0171329.
    PubMed     Text format     Abstract available

  75. HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
    Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    PLoS One. 2017;12:e0171539.
    PubMed     Text format     Abstract available

  76. SUDA K, Rozeboom L, Yu H, Ellison K, et al
    Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
    PLoS One. 2017;12:e0172209.
    PubMed     Text format     Abstract available

  77. CHEN Y, Min L, Ren C, Xu X, et al
    miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.
    PLoS One. 2017;12:e0171751.
    PubMed     Text format     Abstract available

  78. AOKI N, Mochizuki K, Matsui Y
    DNA methylation of the Fthl17 5'-upstream region regulates differential Fthl17 expression in lung cancer cells and germline stem cells.
    PLoS One. 2017;12:e0172219.
    PubMed     Text format     Abstract available

  79. TSUCHIYA N, Doai M, Usuda K, Uramoto H, et al
    Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
    PLoS One. 2017;12:e0172433.
    PubMed     Text format     Abstract available

  80. HUNG MS, Chen IC, Lee CP, Huang RJ, et al
    Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.
    PLoS One. 2017;12:e0171137.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: